产品说明
一般描述
C4 Ceramide (d18:1/4:0) or N-butyroyl-
应用
C4 Ceramide (d18:1/4:0) has been used to study its role in rescuing and stabilizing ΔF508-cystic fibrosis transmembrane conductance regulator (ΔF508-CFTR).
生化/生理作用
C4 Ceramide (d18:1/4:0) is implicated in a series of mutual autophosphorylation and phosphorylation actions between 3-phosphoinositide-dependent kinase 1 (PDK1) and serum/glucocorticoid-induced protein kinase 1 (SGK1). It stimulates cyclic adenosine monophosphate (cAMP)-activated chloride secretion and represses hypersecretion of interleukin-8 (IL-8). C4 Ceramide might be a potential therapeutic for cystic fibrosis (CF).
包装
5 mL Amber Glass Screw Cap Vial (860504P-5mg)
基本信息
经验(实验)分子式 | C22H43NO3 |
分子量 | 369.58 |
NACRES | NA.25 |
产品性质
形式 | powder |
包装 | pkg of 1 × 5 mg (860504P-5mg) |
manufacturer/tradename | Avanti Polar Lipids 860504P |
运输 | dry ice |
储存温度 | −20℃ |
SMILES string | OC[C@]([H])(NC(CCC)=O)[C@]([H])(O)/C=C/CCCCCCCCCCCCC |
安全信息
储存分类代码 | 13 - Non Combustible Solids |
WGK | WGK 3 |
闪点(F) | Not applicable |
闪点(C) | Not applicable |